Citi

Seven banks are set to pitch for lead roles in the Indian government’s sell-down of Oil India, which could add Rp19.7bn ($291.7m) to the state’s coffers based on the company’s market capitalisation.

Yunnan Metropolitan Construction Investment Group Co is looking to join the slew of Chinese local government financing vehicles (LGFV) tapping the offshore bond market.

A vote for the UK to leave the European Union next week could widen the performance rift between sterling and euro bonds and send European credit default swap indices to some of their widest levels this year, Citigroup predicts.

Mahanagar Gas has opened books for its Rp10.4bn ($154.3m) Indian IPO with a valuation that is less than half the average in the utilities sector.

Truly International, the holding company of LCD panel maker Truly Group, has tied up a HK$4.5bn ($580m) four year financing with a group of nine banks.

Cemex Holdings Philippines has kicked off bookbuilding for its potential Ps24.4bn ($526.3m) listing, with the offering covered by cornerstones and anchor investors at the low end of guidance, according to a source with knowledge of the situation.

Enav, the Italian air traffic control system company, began its privatisation IPO on Monday, with the publication of research. Meanwhile, plans are taking shape for the IPO of Avio, the Italian space propulsion firm.

China’s DFZQ, also known as Orient Securities Co, has opened books on an up to HK$8.95bn ($1.16bn) IPO in Hong Kong with a whopping 17 bookrunners crammed into the syndicate.

More than three quarters of Brazilian industrial conglomerate Cosan’s bondholders agreed to sell their bonds in the early bird phase of a tender offer.

Zhongrong International Trust managed to raise $500m this week by compensating investors for its weak fundamentals with a juicy premium over its outstanding bond. But what also helped the deal was a lack of high yield supply from China, reckon bankers.

State Bank of India has allocated its latest $500m borrowing, finding demand from eight new lenders during syndication.

Ethypharm, the French pharmaceutical firm, has allocated a €337m seven year term loan ‘B’ at tighter pricing than initial guidance, following a heavy oversubscription.